A phase Ib study to assess safety and tolerability and neutralising activity of CL184 in healthy volunteers
Phase of Trial: Phase I
Latest Information Update: 30 Nov 2007
At a glance
- Drugs Foravirumab; Rabies vaccine
- Indications Rabies
- Focus Adverse reactions
- Sponsors Crucell
- 14 Nov 2007 The results of this study will be presented on November 30, 2007 at the Joint International Tropical Medicine Meeting 2007 in Bangkok, Thailand.
- 11 Apr 2007 New trial record.